Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Sell
50
CMT Quote, Financials, Valuation and Earnings
Last price:
$15.17
Seasonality move
:
9.93%
Day range:
$15.46 - $15.75
52-week range:
$12.25 - $21.00
Dividend yield:
0%
P/E ratio:
10.22x
P/S ratio:
0.45x
P/B ratio:
0.91x
Volume:
27.8K
Avg. volume:
35.8K
1-year change:
-16.28%
Market cap:
$133.8M
Revenue:
$302.4M
EPS (TTM):
$1.52
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Core Molding Technologies has 41.66% upside to fair value with a price target of $22.00 per share.
CMT vs. S&P 500
-
Over the past 5 trading days, Core Molding Technologies has overperformed the S&P 500 by 1.44% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Core Molding Technologies does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Core Molding Technologies revenues have been falling on a year-over-year basis for 7 quarters in a row. In the most recent quarter Core Molding Technologies reported revenues of $62.5M.
Earnings Growth
-
Core Molding Technologies earnings have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Core Molding Technologies reported earnings per share of --.
Enterprise value:
113.5M
EV / Invested capital:
--
Price / LTM sales:
0.45x
EV / EBIT:
6.36x
EV / Revenue:
0.38x
PEG ratio (5yr expected):
0.35x
EV / Free cash flow:
4.80x
Price / Operating cash flow:
5.77x
Enterprise value / EBITDA:
3.63x
Gross Profit (TTM):
$53.3M
Return On Assets:
6.15%
Net Income Margin (TTM):
4.4%
Return On Equity:
9.18%
Return On Invested Capital:
7.95%
Operating Margin:
2.49%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $377.4M | $357.7M | $302.4M | $73.8M | $62.5M | |
| Gross Profit | $52.3M | $64.5M | $53.3M | $10.9M | $9.9M | |
| Operating Income | $18.4M | $27.1M | $17.5M | $3M | $1.6M | |
| EBITDA | $28.6M | $39.9M | $31.3M | $6.2M | $5.1M | |
| Diluted EPS | $1.45 | $2.29 | $1.52 | $0.23 | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $56.5M | $75.1M | $80.7M | $102.9M | $102.9M | |
| Total Assets | $165.5M | $186.7M | $198.6M | $213.4M | $209.6M | |
| Current Liabilities | $36M | $53.1M | $50.8M | $46.2M | $36.7M | |
| Total Liabilities | $71.6M | $86.6M | $82.5M | $74.4M | $62.2M | |
| Total Equity | $93.9M | $100.1M | $116.1M | $139M | $147.4M | |
| Total Debt | $28.2M | $29.6M | $26.1M | $23M | $21.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $19M | $34.8M | $35.2M | $8.7M | $5M | |
| Cash From Investing | -$16.6M | -$9.1M | -$11.5M | -$2.3M | -$4.5M | |
| Cash From Financing | -$4.4M | -$5.8M | -$5.9M | -$327K | -$1.1M | |
| Free Cash Flow | $2.4M | $25.7M | $23.6M | $6.4M | $509K | |
CMT
Sector
Market Cap
$133.8M
$17.8M
Price % of 52-Week High
73.95%
61.91%
Dividend Yield
0%
0%
Shareholder Yield
--
1.19%
1-Year Price Total Return
-16.28%
-15.62%
Beta (5-Year)
1.040
0.784
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$15.26
200-day SMA
Sell
Level
$16.03
Bollinger Bands (100)
Buy
Level
13.95 - 15.83
Chaikin Money Flow
Buy
Level
77.7K
20-day SMA
Buy
Level
$15.05
Relative Strength Index (RSI14)
Buy
Level
58.89
ADX Line
Buy
Level
18.13
Williams %R
Neutral
Level
-22.9379
50-day SMA
Buy
Level
$14.57
MACD (12, 26)
Buy
Level
1.31
25-day Aroon Oscillator
Sell
Level
-16
On Balance Volume
Sell
Level
-56.1K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.3778)
Buy
CA Score
(Annual)
Level (1.2841)
Buy
Beneish M-Score
(Annual)
Level (-3.2276)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-1.1333)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Core Molding Technologies Inc operates in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. It produces and sells molded products for varied markets, including medium and heavy-duty trucks, automobiles, power sports, construction and agriculture, building products, and other industrial markets. The processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up, direct long-fiber thermoplastics (D-LFT) and structural foam, and structural web injection molding (SIM). It operates operates in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; Matamoros and Escobedo, Mexico; and Cobourg, Ontario, Canada.
Stock Forecast FAQ
In the current month, CMT has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CMT average analyst price target in the past 3 months is $22.00.
-
Where Will Core Molding Technologies Stock Be In 1 Year?
According to analysts, the consensus estimate is that Core Molding Technologies share price will rise to $22.00 per share over the next 12 months.
-
What Do Analysts Say About Core Molding Technologies?
Analysts are divided on their view about Core Molding Technologies share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Core Molding Technologies is a Sell and believe this share price will drop from its current level to $22.00.
-
What Is Core Molding Technologies's Price Target?
The price target for Core Molding Technologies over the next 1-year time period is forecast to be $22.00 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CMT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Core Molding Technologies is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CMT?
You can purchase shares of Core Molding Technologies via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Core Molding Technologies shares.
-
What Is The Core Molding Technologies Share Price Today?
Core Molding Technologies was last trading at $15.17 per share. This represents the most recent stock quote for Core Molding Technologies. Yesterday, Core Molding Technologies closed at $15.53 per share.
-
How To Buy Core Molding Technologies Stock Online?
In order to purchase Core Molding Technologies stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is down 0.07% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 11% over the past day.
